{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:13:15Z","timestamp":1790071995404,"version":"4.0.1"},"reference-count":163,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"FISM","award":["2023 R\/multi-001"],"award-info":[{"award-number":["2023 R\/multi-001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Axons wrapped around the myelin sheath enable fast transmission of neuronal signals in the Central Nervous System (CNS). Unfortunately, myelin can be damaged by injury, viral infection, and inflammatory and neurodegenerative diseases. Remyelination is a spontaneous process that can restore nerve conductivity and thus movement and cognition after a demyelination event. Cumulative evidence indicates that remyelination can be pharmacologically stimulated, either by targeting natural inhibitors of Oligodendrocyte Precursor Cells (OPCs) differentiation or by reactivating quiescent Neural Stem Cells (qNSCs) proliferation and differentiation in myelinating Oligodendrocytes (OLs). Although promising results were obtained in animal models for demyelination diseases, none of the compounds identified have passed all the clinical stages. The significant number of patients who could benefit from remyelination therapies reinforces the urgent need to reassess drug selection approaches and develop strategies that effectively promote remyelination. Integrating Artificial Intelligence (AI)-driven technologies with patient-derived cell-based assays and organoid models is expected to lead to novel strategies and drug screening pipelines to achieve this goal. In this review, we explore the current literature on these technologies and their potential to enhance the identification of more effective drugs for clinical use in CNS remyelination therapies.<\/jats:p>","DOI":"10.3390\/cells13161326","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T07:59:07Z","timestamp":1723190347000},"page":"1326","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Remyelinating Drugs at a Crossroad: How to Improve Clinical Efficacy and Drug Screenings"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8819-5139","authenticated-orcid":false,"given":"Aland Ibrahim Ahmed","family":"Al Jaf","sequence":"first","affiliation":[{"name":"Department of Biology, University of Rome \u201cTor Vergata\u201d, Via della Ricerca Scientifica 1, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9579-3303","authenticated-orcid":false,"given":"Simone","family":"Peria","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Rome \u201cTor Vergata\u201d, Via della Ricerca Scientifica 1, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4622-9147","authenticated-orcid":false,"given":"Tommaso","family":"Fabiano","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Rome \u201cTor Vergata\u201d, Via della Ricerca Scientifica 1, 00133 Rome, Italy"},{"name":"Department of Life Sciences, University of Trieste, 34127 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7963-7554","authenticated-orcid":false,"given":"Antonella","family":"Ragnini-Wilson","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Rome \u201cTor Vergata\u201d, Via della Ricerca Scientifica 1, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrn2480","article-title":"Remyelination in the CNS: From Biology to Therapy","volume":"9","author":"Franklin","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/13524585211008760","article-title":"Current Status of Neuroprotective and Neuroregenerative Strategies in Multiple Sclerosis: A Systematic Review","volume":"28","author":"Allanach","year":"2022","journal-title":"Mult. Scler."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41589-022-01115-2","article-title":"The Landscape of Targets and Lead Molecules for Remyelination","volume":"18","author":"Caprariello","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/13524585221075990","article-title":"Pathways to Cures for Multiple Sclerosis: A Research Roadmap","volume":"28","author":"Bebo","year":"2022","journal-title":"Mult. Scler."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1474-4422(20)30140-X","article-title":"Remyelination in Multiple Sclerosis: From Basic Science to Clinical Translation","volume":"19","author":"Lubetzki","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/brain\/awn080","article-title":"Remyelination Protects Axons from Demyelination-Associated Axon Degeneration","volume":"131","author":"Irvine","year":"2008","journal-title":"Brain"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.expneurol.2016.11.012","article-title":"IPS-Derived Neural Progenitor Cells from PPMS Patients Reveal Defect in Myelin Injury Response","volume":"288","author":"Nicaise","year":"2017","journal-title":"Exp. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Balestri, S., Del Giovane, A., Sposato, C., Ferrarelli, M., and Ragnini-Wilson, A. (2021). The Current Challenges for Drug Discovery in CNS Remyelination. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22062891"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41586-018-0360-3","article-title":"Accumulation of 8,9-Unsaturated Sterols Drives Oligodendrocyte Formation and Remyelination","volume":"560","author":"Hubler","year":"2018","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1021\/acschembio.2c00330","article-title":"Enhancers of Human and Rodent Oligodendrocyte Formation Predominantly Induce Cholesterol Precursor Accumulation","volume":"17","author":"Sax","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Del Giovane, A., Russo, M., Tirou, L., Faure, H., Ruat, M., Balestri, S., Sposato, C., Basoli, F., Rainer, A., and Kassoussi, A. (2021). Smoothened\/AMP-Activated Protein Kinase Signaling in Oligodendroglial Cell Maturation. Front. Cell Neurosci., 15.","DOI":"10.3389\/fncel.2021.801704"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Porcu, G., Serone, E., De Nardis, V., Di Giandomenico, D., Lucisano, G., Scardapane, M., Poma, A., and Ragnini-Wilson, A. (2015). Clobetasol and Halcinonide Act as Smoothened Agonists to Promote Myelin Gene Expression and RxR\u03b3 Receptor Activation. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0144550"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Fang, M., Tang, T., Qiu, M., and Xu, X. (2022). Hedgehog Signaling in CNS Remyelination. Cells, 11.","DOI":"10.3390\/cells11142260"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1523\/JNEUROSCI.1530-18.2019","article-title":"Selective Estrogen Receptor Modulators Enhance CNS Remyelination Independent of Estrogen Receptors","volume":"39","author":"Rankin","year":"2019","journal-title":"J. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12647","article-title":"A Regenerative Approach to the Treatment of Multiple Sclerosis","volume":"502","author":"Deshmukh","year":"2013","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nm.3618","article-title":"Micropillar Arrays as a High-Throughput Screening Platform for Therapeutics in Multiple Sclerosis","volume":"20","author":"Mei","year":"2014","journal-title":"Nat. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature14335","article-title":"Drug-Based Modulation of Endogenous Stem Cells Promotes Functional Remyelination in Vivo","volume":"522","author":"Najm","year":"2015","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2133.1974.tb06385.x","article-title":"The Clinical Evaluation of a New Topical Corticosteroid, Clobetasol Propionate. An International Controlled Trial","volume":"90","author":"Sparkes","year":"1974","journal-title":"Br. J. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1073\/pnas.0910712107","article-title":"Identification of Select Glucocorticoids as Smoothened Agonists: Potential Utility for Regenerative Medicine","volume":"107","author":"Wang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Warrilow, A.G.S., Price, C.L., Parker, J.E., Rolley, N.J., Smyrniotis, C.J., Hughes, D.D., Thoss, V., Nes, W.D., Kelly, D.E., and Holman, T.R. (2016). Azole Antifungal Sensitivity of Sterol 14\u03b1-Demethylase (CYP51) and CYP5218 from Malassezia Globosa. Sci. Rep., 6.","DOI":"10.1038\/srep27690"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.lfs.2018.12.012","article-title":"Triazoles Bind the C-Terminal Domain of SMO: Illustration by Docking and Molecular Dynamics Simulations the Binding between SMO and Triazoles","volume":"217","author":"Liu","year":"2019","journal-title":"Life Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/s41401-018-0206-4","article-title":"Donepezil, a Drug for Alzheimer\u2019s Disease, Promotes Oligodendrocyte Generation and Remyelination","volume":"40","author":"Cui","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/mol.112.084590","article-title":"Discovery, Molecular and Pharmacological Characterization of GSA-10, a Novel Small-Molecule Positive Modulator of Smoothened","volume":"83","author":"Gorojankina","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00415-016-8341-7","article-title":"Lesion Remyelinating Activity of GSK239512 versus Placebo in Patients with Relapsing-Remitting Multiple Sclerosis: A Randomised, Single-Blind, Phase II Study","volume":"264","author":"Schwartzbach","year":"2017","journal-title":"J. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Manousi, A., G\u00f6ttle, P., Reiche, L., Cui, Q.-L., Healy, L.M., Akkermann, R., Gruchot, J., Schira-Heinen, J., Antel, J.P., and Hartung, H.-P. (2021). Identification of Novel Myelin Repair Drugs by Modulation of Oligodendroglial Differentiation Competence. EBioMedicine, 65.","DOI":"10.1016\/j.ebiom.2021.103276"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ccr.2010.02.027","article-title":"Itraconazole, a Commonly Used Antifungal That Inhibits Hedgehog Pathway Activity and Cancer Growth","volume":"17","author":"Kim","year":"2010","journal-title":"Cancer Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1021\/cb300028a","article-title":"Selective Identification of Hedgehog Pathway Antagonists by Direct Analysis of Smoothened Ciliary Translocation","volume":"7","author":"Wang","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"14071","DOI":"10.1073\/pnas.182542899","article-title":"Small Molecule Modulation of Smoothened Activity","volume":"99","author":"Chen","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1038\/ncomms5355","article-title":"Structural Basis for Smoothened Receptor Modulation and Chemoresistance to Anticancer Drugs","volume":"5","author":"Wang","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Lariosa-Willingham, K.D., Rosler, E.S., Tung, J.S., Dugas, J.C., Collins, T.L., and Leonoudakis, D. (2016). A High Throughput Drug Screening Assay to Identify Compounds That Promote Oligodendrocyte Differentiation Using Acutely Dissociated and Purified Oligodendrocyte Precursor Cells. BMC Res. Notes, 9.","DOI":"10.1186\/s13104-016-2220-2"},{"key":"ref_31","unstructured":"(2024, June 24). Home|ClinicalTrials.Gov, Available online: https:\/\/www.clinicaltrials.gov\/."},{"key":"ref_32","unstructured":"(2024, July 10). DrugBank Release Version 5.1.12|DrugBank Online. Available online: https:\/\/go.drugbank.com\/releases\/latest."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Gacem, N., and Nait-Oumesmar, B. (2021). Oligodendrocyte Development and Regenerative Therapeutics in Multiple Sclerosis. Life, 11.","DOI":"10.3390\/life11040327"},{"key":"ref_34","unstructured":"(2024, June 24). Selleckchem.Com\u2014Bioactive Compounds Expert (Bioactive Compounds, Compound Libraries). Available online: https:\/\/www.selleckchem.com\/."},{"key":"ref_35","unstructured":"(2024, June 24). MedChemExpress: Master of Bioactive Molecules|Inhibitors, Screening Libraries & Proteins. Available online: https:\/\/www.medchemexpress.com\/."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Robinson, A.P., Zhang, J.Z., Titus, H.E., Karl, M., Merzliakov, M., Dorfman, A.R., Karlik, S., Stewart, M.G., Watt, R.K., and Facer, B.D. (2020). Nanocatalytic Activity of Clean-Surfaced, Faceted Nanocrystalline Gold Enhances Remyelination in Animal Models of Multiple Sclerosis. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-58709-w"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Fortune, J., Norris, M., Stennett, A., Kilbride, C., Lavelle, G., Hendrie, W., DeSouza, L., Victor, C., and Ryan, J.M. (2021). Correlates of Objectively Measured Physical Activity Among People with Multiple Sclerosis: A Cross-Sectional Study. Front. Rehabil. Sci., 2.","DOI":"10.3389\/fresc.2021.726436"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Hughes, E.G., and Stockton, M.E. (2021). Premyelinating Oligodendrocytes: Mechanisms Underlying Cell Survival and Integration. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.714169"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrn.2017.136","article-title":"Regenerating CNS Myelin\u2014From Mechanisms to Experimental Medicines","volume":"18","author":"Franklin","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcdb.2020.09.009","article-title":"Revisiting Remyelination: Towards a Consensus on the Regeneration of CNS Myelin","volume":"116","author":"Franklin","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e56621","DOI":"10.7554\/eLife.56621","article-title":"Remyelination Alters the Pattern of Myelin in the Cerebral Cortex","volume":"9","author":"Call","year":"2020","journal-title":"eLife"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Kaminska, A., Radoszkiewicz, K., Rybkowska, P., Wedzinska, A., and Sarnowska, A. (2022). Interaction of Neural Stem Cells (NSCs) and Mesenchymal Stem Cells (MSCs) as a Promising Approach in Brain Study and Nerve Regeneration. Cells, 11.","DOI":"10.3390\/cells11091464"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semcdb.2019.01.005","article-title":"Neural Stem Cell Niche Heterogeneity","volume":"95","author":"Andreotti","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.neuron.2014.02.039","article-title":"Prospective Identification and Purification of Quiescent Adult Neural Stem Cells from Their in Vivo Niche","volume":"82","author":"Codega","year":"2014","journal-title":"Neuron"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.scr.2013.02.008","article-title":"Quiescent Neural Stem Cells Exit Dormancy upon Alteration of GABAAR Signaling Following Radiation Damage","volume":"11","author":"Daynac","year":"2013","journal-title":"Stem Cell Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e02669","DOI":"10.7554\/eLife.02669","article-title":"Prospective Identification of Functionally Distinct Stem Cells and Neurosphere-Initiating Cells in Adult Mouse Forebrain","volume":"3","author":"Mich","year":"2014","journal-title":"eLife"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1038\/s41467-019-13203-4","article-title":"Enhanced Lysosomal Degradation Maintains the Quiescent State of Neural Stem Cells","volume":"10","author":"Kobayashi","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41593-020-0637-3","article-title":"Motor Learning Promotes Remyelination via New and Surviving Oligodendrocytes","volume":"23","author":"Bacmeister","year":"2020","journal-title":"Nat. Neurosci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"E11807","DOI":"10.1073\/pnas.1808064115","article-title":"The Adult Oligodendrocyte Can Participate in Remyelination","volume":"115","author":"Duncan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41593-021-01009-x","article-title":"New Oligodendrocytes Exhibit More Abundant and Accurate Myelin Regeneration than Those That Survive Demyelination","volume":"25","author":"Neely","year":"2022","journal-title":"Nat. Neurosci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.cell.2014.10.011","article-title":"Dynamics of Oligodendrocyte Generation and Myelination in the Human Brain","volume":"159","author":"Yeung","year":"2014","journal-title":"Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1523\/JNEUROSCI.3334-12.2013","article-title":"Sonic Hedgehog Signaling Is a Positive Oligodendrocyte Regulator during Demyelination","volume":"33","author":"Ferent","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.stemcr.2014.05.016","article-title":"Genetic Activation of Hedgehog Signaling Unbalances the Rate of Neural Stem Cell Renewal by Increasing Symmetric Divisions","volume":"3","author":"Ferent","year":"2014","journal-title":"Stem Cell Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature14957","article-title":"Inhibition of Gli1 Mobilizes Endogenous Neural Stem Cells for Remyelination","volume":"526","author":"Samanta","year":"2015","journal-title":"Nature"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Moyon, S., Holloman, M., and Salzer, J.L. (2023). Neural Stem Cells and Oligodendrocyte Progenitor Cells Compete for Remyelination in the Corpus Callosum. Front. Cell Neurosci., 17.","DOI":"10.3389\/fncel.2023.1114781"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/neuroglia1010008","article-title":"Sequential Contribution of Parenchymal and Neural Stem Cell-Derived Oligodendrocyte Precursor Cells toward Remyelination","volume":"1","author":"Serwanski","year":"2018","journal-title":"Neuroglia"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1242\/bio.012773","article-title":"Region and Dynamic Specificities of Adult Neural Stem Cells and Oligodendrocyte Precursors in Myelin Regeneration in the Mouse Brain","volume":"4","author":"Brousse","year":"2015","journal-title":"Biol. Open"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.abg8467","article-title":"Release of Stem Cells from Quiescence Reveals Gliogenic Domains in the Adult Mouse Brain","volume":"372","author":"Delgado","year":"2021","journal-title":"Science"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"7907","DOI":"10.1523\/JNEUROSCI.1299-06.2006","article-title":"Origin of Oligodendrocytes in the Subventricular Zone of the Adult Brain","volume":"26","author":"Menn","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1046\/j.1460-9568.1999.00873.x","article-title":"Progenitor Cells of the Adult Mouse Subventricular Zone Proliferate, Migrate and Differentiate into Oligodendrocytes after Demyelination","volume":"11","author":"Decker","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1073\/pnas.0606835104","article-title":"Activation of the Subventricular Zone in Multiple Sclerosis: Evidence for Early Glial Progenitors","volume":"104","author":"Kerninon","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"13211","DOI":"10.1073\/pnas.192314199","article-title":"Experimental Autoimmune Encephalomyelitis Mobilizes Neural Progenitors from the Subventricular Zone to Undergo Oligodendrogenesis in Adult Mice","volume":"99","author":"Decker","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"14128","DOI":"10.1523\/JNEUROSCI.3491-13.2014","article-title":"Adult Neural Precursor Cells from the Subventricular Zone Contribute Significantly to Oligodendrocyte Regeneration and Remyelination","volume":"34","author":"Xing","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/1073858414531457","article-title":"Hedgehog: Multiple Paths for Multiple Roles in Shaping the Brain and Spinal Cord","volume":"21","author":"Ferent","year":"2015","journal-title":"Neuroscientist"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.brainres.2015.10.051","article-title":"Oligodendrocyte Progenitor Programming and Reprogramming: Toward Myelin Regeneration","volume":"1638","author":"He","year":"2016","journal-title":"Brain Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41580-022-00568-6","article-title":"Regulation of Adult Stem Cell Quiescence and Its Functions in the Maintenance of Tissue Integrity","volume":"24","author":"Rando","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature18934","article-title":"Structural Basis of Smoothened Regulation by Its Extracellular Domains","volume":"535","author":"Byrne","year":"2016","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e20304","DOI":"10.7554\/eLife.20304","article-title":"Cholesterol Activates the G-Protein Coupled Receptor Smoothened to Promote Hedgehog Signaling","volume":"5","author":"Luchetti","year":"2016","journal-title":"eLife"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1038\/ncomms3965","article-title":"Structural Insights into the Role of the Smoothened Cysteine-Rich Domain in Hedgehog Signalling","volume":"4","author":"Rana","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Qiu, Z.-P., Hu, A., and Song, B.-L. (2021). The 3-Beta-Hydroxysteroid-Delta(8), Delta(7)-Isomerase EBP Inhibits Cholesterylation of Smoothened. Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 1866.","DOI":"10.1016\/j.bbalip.2021.159041"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/glia.24540","article-title":"Activation of Shh\/Smo Is Sufficient to Maintain Oligodendrocyte Precursor Cells in an Undifferentiated State and Is Not Necessary for Myelin Formation and (Re)Myelination","volume":"72","author":"Nocera","year":"2024","journal-title":"Glia"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s13287-019-1374-y","article-title":"Temporal and Partial Inhibition of GLI1 in Neural Stem Cells (NSCs) Results in the Early Maturation of NSC Derived Oligodendrocytes in Vitro","volume":"10","author":"Namchaiw","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.stemcr.2020.10.003","article-title":"Relative Levels of Gli1 and Gli2 Determine the Response of Ventral Neural Stem Cells to Demyelination","volume":"15","author":"Radecki","year":"2020","journal-title":"Stem Cell Rep."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/1873-3468.12999","article-title":"Epigenetic Modifications-Insight into Oligodendrocyte Lineage Progression, Regeneration, and Disease","volume":"592","author":"Gregath","year":"2018","journal-title":"FEBS Lett."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.stem.2010.04.002","article-title":"CNS-Resident Glial Progenitor\/Stem Cells Produce Schwann Cells as Well as Oligodendrocytes during Repair of CNS Demyelination","volume":"6","author":"Zawadzka","year":"2010","journal-title":"Cell Stem Cell"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.1190927","article-title":"Regulation of Oligodendrocyte Differentiation and Myelination","volume":"330","author":"Emery","year":"2010","journal-title":"Science"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00401-017-1741-7","article-title":"Myelin Regulatory Factor Drives Remyelination in Multiple Sclerosis","volume":"134","author":"Duncan","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Duncan, G.J., Simkins, T.J., and Emery, B. (2021). Neuron-Oligodendrocyte Interactions in the Structure and Integrity of Axons. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.653101"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00415-019-09421-x","article-title":"Promoting Remyelination in Multiple Sclerosis","volume":"268","author":"Cunniffe","year":"2021","journal-title":"J. Neurol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41586-019-0903-2","article-title":"Altered Human Oligodendrocyte Heterogeneity in Multiple Sclerosis","volume":"566","author":"Agirre","year":"2019","journal-title":"Nature"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s41467-021-20892-3","article-title":"Single-Cell Transcriptomic Reveals Molecular Diversity and Developmental Heterogeneity of Human Stem Cell-Derived Oligodendrocyte Lineage Cells","volume":"12","author":"Chamling","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41586-018-0842-3","article-title":"Dynamics of Oligodendrocyte Generation in Multiple Sclerosis","volume":"566","author":"Yeung","year":"2019","journal-title":"Nature"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.neuron.2022.09.023","article-title":"CNS Remyelination and Inflammation: From Basic Mechanisms to Therapeutic Opportunities","volume":"110","author":"Franklin","year":"2022","journal-title":"Neuron"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.tins.2016.02.004","article-title":"Pushing Forward: Remyelination as the New Frontier in CNS Diseases","volume":"39","author":"Kremer","year":"2016","journal-title":"Trends Neurosci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41582-023-00801-6","article-title":"Inflammation in Multiple Sclerosis: Consequences for Remyelination and Disease Progression","volume":"19","author":"Klotz","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00401-020-02217-8","article-title":"Extrinsic Immune Cell-Derived, but Not Intrinsic Oligodendroglial Factors Contribute to Oligodendroglial Differentiation Block in Multiple Sclerosis","volume":"140","author":"Starost","year":"2020","journal-title":"Acta Neuropathol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s12264-023-01034-9","article-title":"Glia Connect Inflammation and Neurodegeneration in Multiple Sclerosis","volume":"39","author":"Sun","year":"2023","journal-title":"Neurosci. Bull."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of Multiple Sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41586-022-04419-4","article-title":"Twin Study Reveals Non-Heritable Immune Perturbations in Multiple Sclerosis","volume":"603","author":"Ingelfinger","year":"2022","journal-title":"Nature"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00401-014-1310-2","article-title":"Macrophage Subsets and Microglia in Multiple Sclerosis","volume":"128","author":"Bogie","year":"2014","journal-title":"Acta Neuropathol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrneurol.2016.110","article-title":"Myeloid Cells\u2014Targets of Medication in Multiple Sclerosis","volume":"12","author":"Mishra","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/ana.410380514","article-title":"Monocyte\/Macrophage Differentiation in Early Multiple Sclerosis Lesions","volume":"38","author":"Porada","year":"1995","journal-title":"Ann. Neurol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrn3898","article-title":"Astrocyte Barriers to Neurotoxic Inflammation","volume":"16","author":"Sofroniew","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s40478-018-0628-8","article-title":"The Physiology of Foamy Phagocytes in Multiple Sclerosis","volume":"6","author":"Grajchen","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1002\/jnr.22434","article-title":"Chemical Inducers and Transcriptional Markers of Oligodendrocyte Differentiation","volume":"88","author":"Joubert","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1007\/s11064-010-0318-9","article-title":"Glial Cell Lines: An Overview","volume":"35","author":"Boullerne","year":"2010","journal-title":"Neurochem. Res."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Nocita, E., Del Giovane, A., Tiberi, M., Boccuni, L., Fiorelli, D., Sposato, C., Romano, E., Basoli, F., Trombetta, M., and Rainer, A. (2019). EGFR\/ErbB Inhibition Promotes OPC Maturation up to Axon Engagement by Co-Regulating PIP2 and MBP. Cells, 8.","DOI":"10.3390\/cells8080844"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nmeth.2105","article-title":"A Culture System to Study Oligodendrocyte Myelination Processes Using Engineered Nanofibers","volume":"9","author":"Lee","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.cub.2015.07.056","article-title":"CNS Myelin Sheath Lengths Are an Intrinsic Property of Oligodendrocytes","volume":"25","author":"Bechler","year":"2015","journal-title":"Curr. Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"7925","DOI":"10.1523\/JNEUROSCI.1493-16.2016","article-title":"Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination","volume":"36","author":"Mei","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Espinosa-Hoyos, D., Jagielska, A., Homan, K.A., Du, H., Busbee, T., Anderson, D.G., Fang, N.X., Lewis, J.A., and Van Vliet, K.J. (2018). Engineered 3D-Printed Artificial Axons. Sci. Rep., 8.","DOI":"10.1038\/s41598-017-18744-6"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.chembiol.2019.01.004","article-title":"Diverse Chemical Scaffolds Enhance Oligodendrocyte Formation by Inhibiting CYP51, TM7SF2, or EBP","volume":"26","author":"Allimuthu","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1021\/acsptsci.9b00068","article-title":"Remyelination Pharmacotherapy Investigations Highlight Diverse Mechanisms Underlying Multiple Sclerosis Progression","volume":"2","author":"Melchor","year":"2019","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Del Giovane, A., and Ragnini-Wilson, A. (2018). Targeting Smoothened as a New Frontier in the Functional Recovery of Central Nervous System Demyelinating Pathologies. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113677"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","article-title":"Clemastine Fumarate as a Remyelinating Therapy for Multiple Sclerosis (ReBUILD): A Randomised, Controlled, Double-Blind, Crossover Trial","volume":"390","author":"Green","year":"2017","journal-title":"Lancet"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Patel, L., Shukla, T., Huang, X., Ussery, D.W., and Wang, S. (2020). Machine Learning Methods in Drug Discovery. Molecules, 25.","DOI":"10.3390\/molecules25225277"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Alowais, S.A., Alghamdi, S.S., Alsuhebany, N., Alqahtani, T., Alshaya, A.I., Almohareb, S.N., Aldairem, A., Alrashed, M., Bin Saleh, K., and Badreldin, H.A. (2023). Revolutionizing Healthcare: The Role of Artificial Intelligence in Clinical Practice. BMC Med. Educ., 23.","DOI":"10.1186\/s12909-023-04698-z"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0840470419873123","article-title":"Artificial Intelligence in Healthcare: An Essential Guide for Health Leaders","volume":"33","author":"Chen","year":"2020","journal-title":"Healthc. Manag. Forum"},{"key":"ref_109","first-page":"e45412","article-title":"Artificial Intelligence and Multiple Sclerosis: Up-to-Date Review","volume":"15","author":"Naji","year":"2023","journal-title":"Cureus"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Ostellino, S., Benso, A., and Politano, G. (2022). The Integration of Clinical Data in the Assessment of Multiple Sclerosis\u2014A Review. Comput. Methods Programs Biomed., 221.","DOI":"10.1016\/j.cmpb.2022.106900"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of Multiple Sclerosis: 2017 Revisions of the McDonald Criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"103673","DOI":"10.1016\/j.msard.2022.103673","article-title":"Artificial Intelligence in the Diagnosis of Multiple Sclerosis: A Systematic Review","volume":"59","author":"Nabizadeh","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Marzullo, A., Kocevar, G., Stamile, C., Calimeri, F., Terracina, G., Durand-Dubief, F., and Sappey-Marinier, D. (2019, January 23\u201327). Prediction of Multiple Sclerosis Patient Disability from Structural Connectivity Using Convolutional Neural Networks. Proceedings of the 2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Berlin, Germany.","DOI":"10.1109\/EMBC.2019.8856845"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"102652","DOI":"10.1016\/j.nicl.2021.102652","article-title":"DeepGRAI (Deep Gray Rating via Artificial Intelligence): Fast, Feasible, and Clinically Relevant Thalamic Atrophy Measurement on Clinical Quality T2-FLAIR MRI in Multiple Sclerosis","volume":"30","author":"Dwyer","year":"2021","journal-title":"Neuroimage Clin."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"100053","DOI":"10.1016\/j.xcrm.2020.100053","article-title":"Inferring Multiple Sclerosis Stages from the Blood Transcriptome via Machine Learning","volume":"1","author":"Acquaviva","year":"2020","journal-title":"Cell Rep. Med."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Plati, D., Tripoliti, E., Zelilidou, S., Vlachos, K., Konitsiotis, S., and Fotiadis, D.I. (2022, January 11\u201315). Multiple Sclerosis Severity Estimation and Progression Prediction Based on Machine Learning Techniques. Proceedings of the 2022 44th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC), Glasgow, UK.","DOI":"10.1109\/EMBC48229.2022.9871213"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1109\/TBME.2020.3048142","article-title":"Predicting Multiple Sclerosis from Gait Dynamics Using an Instrumented Treadmill: A Machine Learning Approach","volume":"68","author":"Kaur","year":"2021","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Hu, W., Combden, O., Jiang, X., Buragadda, S., Newell, C.J., Williams, M.C., Critch, A.L., and Ploughman, M. (2022). Machine Learning Classification of Multiple Sclerosis Patients Based on Raw Data from an Instrumented Walkway. Biomed. Eng. Online, 21.","DOI":"10.1186\/s12938-022-00992-x"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Denissen, S., Ch\u00e9n, O.Y., De Mey, J., De Vos, M., Van Schependom, J., Sima, D.M., and Nagels, G. (2021). Towards Multimodal Machine Learning Prediction of Individual Cognitive Evolution in Multiple Sclerosis. J. Pers. Med., 11.","DOI":"10.3390\/jpm11121349"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Khaligh-Razavi, S.-M., Sadeghi, M., Khanbagi, M., Kalafatis, C., and Nabavi, S.M. (2020). A Self-Administered, Artificial Intelligence (AI) Platform for Cognitive Assessment in Multiple Sclerosis (MS). BMC Neurol., 20.","DOI":"10.1186\/s12883-020-01736-x"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Svoboda, E., Bo\u0159il, T., Rusz, J., Tykalov\u00e1, T., Hor\u00e1kov\u00e1, D., Guttmann, C.R.G., Blagoev, K.B., Hatabu, H., and Valtchinov, V.I. (2022). Assessing Clinical Utility of Machine Learning and Artificial Intelligence Approaches to Analyze Speech Recordings in Multiple Sclerosis: A Pilot Study. Comput. Biol. Med., 148.","DOI":"10.1016\/j.compbiomed.2022.105853"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1021\/acschemneuro.1c00087","article-title":"Emerging Application of Nanorobotics and Artificial Intelligence to Cross the BBB: Advances in Design, Controlled Maneuvering, and Targeting of the Barriers","volume":"12","author":"Singh","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Voigt, I., Inojosa, H., Dillenseger, A., Haase, R., Akg\u00fcn, K., and Ziemssen, T. (2021). Digital Twins for Multiple Sclerosis. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.669811"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1299833","DOI":"10.1080\/20016689.2017.1299833","article-title":"Filling the Gap in CNS Drug Development: Evaluation of the Role of Drug Repurposing","volume":"5","author":"Caban","year":"2017","journal-title":"J. Mark. Access Health Policy"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Mihai, D.P., Nitulescu, G.M., Ion, G.N.D., Ciotu, C.I., Chirita, C., and Negres, S. (2019). Computational Drug Repurposing Algorithm Targeting TRPA1 Calcium Channel as a Potential Therapeutic Solution for Multiple Sclerosis. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11090446"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"10143","DOI":"10.1523\/JNEUROSCI.5779-12.2013","article-title":"TRPA1 Channels Are Regulators of Astrocyte Basal Calcium Levels and Long-Term Potentiation via Constitutive D-Serine Release","volume":"33","author":"Shigetomi","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2018.03.020","article-title":"Behavioural Alterations and Morphological Changes Are Attenuated by the Lack of TRPA1 Receptors in the Cuprizone-Induced Demyelination Model in Mice","volume":"320","author":"Kriszta","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"104622","DOI":"10.1016\/j.msard.2023.104622","article-title":"In Silico Repurposing of CNS Drugs for Multiple Sclerosis","volume":"73","author":"Sardari","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1074\/jbc.M115.700385","article-title":"Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple Sclerosis","volume":"291","author":"Warne","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1021\/jm500338n","article-title":"Orally Active 7-Substituted (4-Benzylphthalazin-1-Yl)-2-Methylpiperazin-1-Yl]Nicotinonitriles as Active-Site Inhibitors of Sphingosine 1-Phosphate Lyase for the Treatment of Multiple Sclerosis","volume":"57","author":"Weiler","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"103839","DOI":"10.1016\/j.msard.2022.103839","article-title":"Using MS Induced Pluripotent Stem Cells to Investigate MS Aetiology","volume":"63","author":"Fortune","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1126\/science.aad3839","article-title":"Oligodendrocyte Precursors Migrate along Vasculature in the Developing Nervous System","volume":"351","author":"Tsai","year":"2016","journal-title":"Science"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41380-019-0495-0","article-title":"The Application of Human Pluripotent Stem Cells to Model the Neuronal and Glial Components of Neurodevelopmental Disorders","volume":"25","author":"Lee","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Nicaise, A.M., Willis, C.M., Crocker, S.J., and Pluchino, S. (2020). Stem Cells of the Aging Brain. Front. Aging Neurosci., 12.","DOI":"10.3389\/fnagi.2020.00247"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Zeldich, E., and Rajkumar, S. (2024). Identity and Maturity of IPSC-Derived Oligodendrocytes in 2D and Organoid Systems. Cells, 13.","DOI":"10.3390\/cells13080674"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.stem.2012.12.002","article-title":"Human IPSC-Derived Oligodendrocyte Progenitor Cells Can Myelinate and Rescue a Mouse Model of Congenital Hypomyelination","volume":"12","author":"Wang","year":"2013","journal-title":"Cell Stem Cell"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.stem.2016.10.015","article-title":"Neural Subtype Specification from Human Pluripotent Stem Cells","volume":"19","author":"Tao","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.mcn.2006.11.008","article-title":"Human Oligodendrocytes Derived from Embryonic Stem Cells: Effect of Noggin on Phenotypic Differentiation in Vitro and on Myelination in Vivo","volume":"34","author":"Izrael","year":"2007","journal-title":"Mol. Cell Neurosci."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1242\/dev.01273","article-title":"Interactions between ID and OLIG Proteins Mediate the Inhibitory Effects of BMP4 on Oligodendroglial Differentiation","volume":"131","author":"Samanta","year":"2004","journal-title":"Development"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1242\/dev.029447","article-title":"Human Oligodendrocytes from Embryonic Stem Cells: Conserved SHH Signaling Networks and Divergent FGF Effects","volume":"136","author":"Hu","year":"2009","journal-title":"Development"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Klein, J.A., Li, Z., Rampam, S., Cardini, J., Ayoub, A., Shaw, P., Rachubinski, A.L., Espinosa, J.M., Zeldich, E., and Haydar, T.F. (2021). Sonic Hedgehog Pathway Modulation Normalizes Expression of Olig2 in Rostrally Patterned NPCs With Trisomy 21. Front. Cell Neurosci., 15.","DOI":"10.3389\/fncel.2021.794675"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00401-021-02390-4","article-title":"Oligodendroglia Heterogeneity in the Human Central Nervous System","volume":"143","author":"Seeker","year":"2022","journal-title":"Acta Neuropathol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.stemcr.2015.11.013","article-title":"Grafted Human IPS Cell-Derived Oligodendrocyte Precursor Cells Contribute to Robust Remyelination of Demyelinated Axons after Spinal Cord Injury","volume":"6","author":"Kawabata","year":"2016","journal-title":"Stem Cell Rep."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nbt.1529","article-title":"Highly Efficient Neural Conversion of Human ES and IPS Cells by Dual Inhibition of SMAD Signaling","volume":"27","author":"Chambers","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.stemcr.2014.06.012","article-title":"Efficient Generation of Myelinating Oligodendrocytes from Primary Progressive Multiple Sclerosis Patients by Induced Pluripotent Stem Cells","volume":"3","author":"Douvaras","year":"2014","journal-title":"Stem Cell Rep."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/nprot.2015.075","article-title":"Generation and Isolation of Oligodendrocyte Progenitor Cells from Human Pluripotent Stem Cells","volume":"10","author":"Douvaras","year":"2015","journal-title":"Nat. Protoc."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41593-020-00786-1","article-title":"Activity-Dependent Regulome of Human GABAergic Neurons Reveals New Patterns of Gene Regulation and Neurological Disease Heritability","volume":"24","author":"Boulting","year":"2021","journal-title":"Nat. Neurosci."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.stem.2016.04.013","article-title":"Induced Pluripotent Stem Cells Meet Genome Editing","volume":"18","author":"Hockemeyer","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13229-021-00417-x","article-title":"Mind the Translational Gap: Using IPS Cell Models to Bridge from Genetic Discoveries to Perturbed Pathways and Therapeutic Targets","volume":"12","author":"Pintacuda","year":"2021","journal-title":"Mol. Autism"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1242\/dev.126409","article-title":"How to Make an Oligodendrocyte","volume":"142","author":"Goldman","year":"2015","journal-title":"Development"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.stemcr.2014.03.007","article-title":"Involvement of ER Stress in Dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 Missense Mutations Shown by IPSC-Derived Oligodendrocytes","volume":"2","author":"Okada","year":"2014","journal-title":"Stem Cell Rep."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Shaker, M.R., Pietrogrande, G., Martin, S., Lee, J.-H., Sun, W., and Wolvetang, E.J. (2021). Rapid and Efficient Generation of Myelinating Human Oligodendrocytes in Organoids. Front. Cell Neurosci., 15.","DOI":"10.3389\/fncel.2021.631548"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Daviaud, N., Chen, E., Edwards, T., and Sadiq, S.A. (2023). Cerebral Organoids in Primary Progressive Multiple Sclerosis Reveal Stem Cell and Oligodendrocyte Differentiation Defect. Biol. Open, 12.","DOI":"10.1242\/bio.059845"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/sctm.19-0455","article-title":"Rapid Induction of Gliogenesis in OLIG2 and NKX2.2-Expressing Progenitors-Derived Spheroids","volume":"9","author":"Yun","year":"2020","journal-title":"Stem Cells Transl. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.stemcr.2019.04.011","article-title":"Pluripotent Stem Cell-Derived Cerebral Organoids Reveal Human Oligodendrogenesis with Dorsal and Ventral Origins","volume":"12","author":"Kim","year":"2019","journal-title":"Stem Cell Rep."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"102725","DOI":"10.1016\/j.xpro.2023.102725","article-title":"Protocol for Generating Embedding-Free Brain Organoids Enriched with Oligodendrocytes","volume":"4","author":"Marti","year":"2023","journal-title":"STAR Protoc."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"100443","DOI":"10.1016\/j.xpro.2021.100443","article-title":"Generation of Human Pluripotent Stem Cell-Derived Fused Organoids with Oligodendroglia and Myelin","volume":"2","author":"Kim","year":"2021","journal-title":"STAR Protoc."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1038\/s41596-019-0213-z","article-title":"Generation of Blood Vessel Organoids from Human Pluripotent Stem Cells","volume":"14","author":"Wimmer","year":"2019","journal-title":"Nat. Protoc."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s13365-022-01062-7","article-title":"A Human-Derived 3D Brain Organoid Model to Study JC Virus Infection","volume":"28","author":"Barreras","year":"2022","journal-title":"J. Neurovirol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.devcel.2021.04.006","article-title":"IPSC-Derived Myelinoids to Study Myelin Biology of Humans","volume":"56","author":"James","year":"2021","journal-title":"Dev. Cell"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/16\/1326\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:32:33Z","timestamp":1760110353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/16\/1326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":163,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["cells13161326"],"URL":"https:\/\/doi.org\/10.3390\/cells13161326","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,8]]}}}